FEMSelect
Convertible Note in 2024
FEMSelect Inc., founded in 2012, is a medical device company focused on improving women's health through innovative surgical solutions. Based in Newark, Delaware, FEMSelect develops minimally-invasive and mesh-free systems for pelvic floor ligament fixation. Their flagship product, EnPlace, is designed to treat pelvic organ prolapse (POP) by precisely guiding, inserting, and deploying an anchor unit through the vaginal wall to stabilize the pelvic floor ligament. The procedure typically takes around 30 minutes and does not require overnight hospital stays or result in significant scarring.
FEMSelect
Series B in 2022
FEMSelect Inc., founded in 2012, is a medical device company focused on improving women's health through innovative surgical solutions. Based in Newark, Delaware, FEMSelect develops minimally-invasive and mesh-free systems for pelvic floor ligament fixation. Their flagship product, EnPlace, is designed to treat pelvic organ prolapse (POP) by precisely guiding, inserting, and deploying an anchor unit through the vaginal wall to stabilize the pelvic floor ligament. The procedure typically takes around 30 minutes and does not require overnight hospital stays or result in significant scarring.
AnaOno is a lingerie and apparel brand that serves women who have undergone breast surgery, mastectomy, or reconstruction. It designs wire-free undergarments and loungewear from soft materials, with attention to different breast shapes and surgery types, and offers feminine details and comfortable silhouettes to provide practical and supportive options during recovery and beyond.
FEMSelect
Convertible Note in 2020
FEMSelect Inc., founded in 2012, is a medical device company focused on improving women's health through innovative surgical solutions. Based in Newark, Delaware, FEMSelect develops minimally-invasive and mesh-free systems for pelvic floor ligament fixation. Their flagship product, EnPlace, is designed to treat pelvic organ prolapse (POP) by precisely guiding, inserting, and deploying an anchor unit through the vaginal wall to stabilize the pelvic floor ligament. The procedure typically takes around 30 minutes and does not require overnight hospital stays or result in significant scarring.
FEMSelect
Convertible Note in 2020
FEMSelect Inc., founded in 2012, is a medical device company focused on improving women's health through innovative surgical solutions. Based in Newark, Delaware, FEMSelect develops minimally-invasive and mesh-free systems for pelvic floor ligament fixation. Their flagship product, EnPlace, is designed to treat pelvic organ prolapse (POP) by precisely guiding, inserting, and deploying an anchor unit through the vaginal wall to stabilize the pelvic floor ligament. The procedure typically takes around 30 minutes and does not require overnight hospital stays or result in significant scarring.
DailyWorth
Series A in 2013
DailyWorth is a prominent financial media company focused on empowering women through financial education and advisory services. It offers a multi-platform approach that includes publications and resources covering various aspects of personal finance, such as saving, investing, and retirement planning. By providing tailored financial content, DailyWorth aims to engage women and enhance their financial literacy, helping them build their net worth and self-worth. The company's mission is to support women in making informed financial decisions, ultimately contributing to their overall joy and financial well-being.
DailyWorth
Venture Round in 2011
DailyWorth is a prominent financial media company focused on empowering women through financial education and advisory services. It offers a multi-platform approach that includes publications and resources covering various aspects of personal finance, such as saving, investing, and retirement planning. By providing tailored financial content, DailyWorth aims to engage women and enhance their financial literacy, helping them build their net worth and self-worth. The company's mission is to support women in making informed financial decisions, ultimately contributing to their overall joy and financial well-being.
FEMSelect Inc., founded in 2012, is a medical device company focused on improving women's health through innovative surgical solutions. Based in Newark, Delaware, FEMSelect develops minimally-invasive and mesh-free systems for pelvic floor ligament fixation. Their flagship product, EnPlace, is designed to treat pelvic organ prolapse (POP) by precisely guiding, inserting, and deploying an anchor unit through the vaginal wall to stabilize the pelvic floor ligament. The procedure typically takes around 30 minutes and does not require overnight hospital stays or result in significant scarring.